OBJECTIVE: To determine the incidence of postoperative junctional @entity591 (JET), we reviewed 343 consecutive @entity1 undergoing surgery between 1997 and 1999. The impact of this @entity943 on in-hospital morbidity and our protocol for treatment were assessed. METHODS: We reviewed the postoperative course of @entity1 undergoing surgery for @entity1757 ( @entity1757 ; n=161), @entity215 ( @entity215 ; n=114), @entity474 ( @entity474 ; n=58) and common arterial trunk (n=10). All @entity1 with JET received treatment, in a stepwise manner, beginning with surface cooling, continuous intravenous @entity2643 , and/or atrial pacing if the haemodynamics proved unstable. A linear regression model assessed the effect of these treatments upon hours of mechanical ventilation, and stay on the @entity299 ( @entity299 ). RESULTS: Overall mortality was 2.9% (n=10), with three of these @entity1 having JET and @entity215 . JET occurred in 37 @entity1 (10.8%), most frequently after @entity215 repair (21.9%), followed by @entity474 (10.3%), @entity1757 (3.7%), and with no occurrence after repair of common arterial trunk. Mean ventilation time increased from 83 to 187 h amongst @entity1 without and with JET @entity1 (P<0.0001). Accordingly, @entity299 stay increased from 107 to 210 h when JET occurred (P<0.0001). Surface cooling was associated with a prolongation of ventilation and @entity299 stay, by 74 and 81 h, respectively (P<0.02; P<0.02). @entity2643 prolonged ventilation and @entity299 stay, respectively, by 274 and 275 h (P<0.05; P<0.06). CONCLUSIONS: Postoperative JET adds considerably to morbidity after congenital cardiac surgery, and is particularly frequent after @entity215 repair. Aggressive treatment with cooling and/or @entity2643 is mandatory, but correlates with increased mechanical ventilation time and @entity299 stay. Better understanding of the mechanism underlying JET is required to achieve prevention, faster arrhythmic conversion, and reduction of associated in-hospital morbidity.

Impact of junctional XXXX on postoperative morbidity following repair of congenital heart defects.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity2643 :: ('MESH:D000638', 'Chemical') :: ['amiodarone', 'Amiodarone'] @entity215 :: ('MESH:D013771', 'Disease') :: ['TOF', 'tetralogy of Fallot'] @entity1757 :: ('MESH:D006345', 'Disease') :: ['VSD', 'ventricular septal defect'] @entity474 :: ('MESH:C562831', 'Disease') :: ['atrioventricular septal defect', 'AVSD'] @entity591 :: ('MESH:D013610', 'Disease') :: ['ectopic tachycardia'] @entity299 :: ('MESH:D006331', 'Disease') :: ['CICU', 'cardiac intensive care unit'] @entity943 :: ('MESH:D001145', 'Disease') :: ['arrhythmia']
@entity591 :: (MESH:D013610,Disease) :: ['ectopic tachycardia']
